NCT02758431View on ClinicalTrials.gov

Cardiovascular Outcomes of Low Testosterone

NACompletedINTERVENTIONAL
Enrollment

232

Participants

Timeline

Start Date

July 1, 2016

Primary Completion Date

January 4, 2023

Study Completion Date

January 4, 2023

Conditions
Hypogonadism
Interventions
DRUG

Acyline

Acyline 300ug/kg injection will be administered on Day 0 and on day 14

DRUG

Placebo Gel

Placebo gel packet applied daily for 28 days.

DRUG

Placebo Tablet

Placebo oral tablet taken daily for 28 days.

DRUG

Testosterone Gel

Testosterone Gel applied daily for 28 days

DRUG

Arimidex

Arimidex Oral Tablet 1mg taken orally daily for 28 days

Trial Locations (1)

80045

University of Colorado CCTSI CTRC, Denver

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

University of Colorado, Denver

OTHER

NCT02758431 - Cardiovascular Outcomes of Low Testosterone | Biotech Hunter | Biotech Hunter